Michele Colucci, Co-founder/Managing Partner, is a lawyer, investor, serial entrepreneur, and philanthropist. DigitalDx Ventures I, L.P. is focused on investments that help doctors better understand their patients’ condition and make more personalized and effective treatment decisions. Their investments are designed to have a measurable positive impact on global health while simultaneously delivering superior financial market returns. Their portfolio companies seek to address medical conditions collectively affecting 2 billion lives or more world-wide. 100% of portfolio companies develop solutions to enable early detection of targeted medical conditions, with less invasive standards of care, with a preference for completely non- invasive solutions that are less expensive than the current standard of care and with over 90% diagnostic accuracy. Over 50% of portfolio companies have women as founders or in the C-suite.

Currently, Michele serves on public and private Boards of Directors at Global Indemnity Group, Nephrosant, Optina Diagnostics, Prime Genomics, and Trayt. She is also an Advisor to eHealth Analytics (a digital health startup) and Quantellia (a platform powering decision-based analytics through artificial intelligence). She is a Huffington Postblogger on female entrepreneurship and an award-winning expert on E-Local. She has served as a regular guest lecturer and mentor at Stanford University’s School of Engineering focused on Global Marketing and Entrepreneurship and has lectured at USC’s Gould School of Law.